State of Alaska Department of Revenue’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-9,710
| Closed | -$252K | – | 1612 |
|
2023
Q2 | $252K | Sell |
9,710
-294
| -3% | -$7.63K | ﹤0.01% | 1574 |
|
2023
Q1 | $287K | Sell |
10,004
-169
| -2% | -$4.85K | ﹤0.01% | 1550 |
|
2022
Q4 | $301K | Buy |
10,173
+65
| +0.6% | +$1.92K | ﹤0.01% | 1541 |
|
2022
Q3 | $240K | Sell |
10,108
-76
| -0.7% | -$1.81K | ﹤0.01% | 1561 |
|
2022
Q2 | $227K | Buy |
10,184
+140
| +1% | +$3.12K | ﹤0.01% | 1578 |
|
2022
Q1 | $252K | Sell |
10,044
-180
| -2% | -$4.52K | ﹤0.01% | 1563 |
|
2021
Q4 | $366K | Sell |
10,224
-300
| -3% | -$10.7K | ﹤0.01% | 1548 |
|
2021
Q3 | $447K | Buy |
10,524
+570
| +6% | +$24.2K | ﹤0.01% | 1504 |
|
2021
Q2 | $430K | Buy |
9,954
+230
| +2% | +$9.94K | ﹤0.01% | 1496 |
|
2021
Q1 | $396K | Sell |
9,724
-1,340
| -12% | -$54.6K | ﹤0.01% | 1499 |
|
2020
Q4 | $500K | Sell |
11,064
-2,230
| -17% | -$101K | 0.01% | 1353 |
|
2020
Q3 | $470K | Buy |
13,294
+230
| +2% | +$8.13K | 0.01% | 1265 |
|
2020
Q2 | $492K | Sell |
13,064
-170
| -1% | -$6.4K | 0.01% | 1248 |
|
2020
Q1 | $382K | Buy |
13,234
+2,455
| +23% | +$70.9K | 0.01% | 1223 |
|
2019
Q4 | $558K | Buy |
10,779
+191
| +2% | +$9.89K | 0.01% | 1259 |
|
2019
Q3 | $581K | Buy |
10,588
+5,751
| +119% | +$316K | 0.01% | 1194 |
|
2019
Q2 | $196K | Buy |
4,837
+50
| +1% | +$2.03K | ﹤0.01% | 1459 |
|
2019
Q1 | $144K | Buy |
4,787
+35
| +0.7% | +$1.05K | ﹤0.01% | 1537 |
|
2018
Q4 | $159K | Sell |
4,752
-110
| -2% | -$3.68K | ﹤0.01% | 1481 |
|
2018
Q3 | $205K | Buy |
4,862
+40
| +0.8% | +$1.69K | ﹤0.01% | 1497 |
|
2018
Q2 | $154K | Buy |
4,822
+90
| +2% | +$2.87K | ﹤0.01% | 1539 |
|
2018
Q1 | $235K | Buy |
4,732
+1,830
| +63% | +$90.9K | ﹤0.01% | 1347 |
|
2017
Q4 | $156K | Hold |
2,902
| – | – | ﹤0.01% | 1389 |
|
2017
Q3 | $168K | Buy |
2,902
+30
| +1% | +$1.74K | 0.01% | 1064 |
|
2017
Q2 | $141K | Buy |
2,872
+1,272
| +80% | +$62.4K | 0.01% | 999 |
|
2017
Q1 | $69K | Hold |
1,600
| – | – | 0.01% | 1049 |
|
2016
Q4 | $78K | Buy |
+1,600
| New | +$78K | 0.01% | 730 |
|